CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD Q2 2016 significant ownership

CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Clearwire Corp /DENovember 06, 201234,086,5544.9%
THERAVANCE INCFebruary 14, 20123,609,3074.2%
FACET BIOTECH CORPMarch 10, 20101,162,7114.6%
EMMIS COMMUNICATIONS CORPJuly 14, 20091,338,6604.2%
BRADLEY PHARMACEUTICALS INCSold outFebruary 14, 200800.0%
GENTEK INCFebruary 14, 20081,007,8399.5%
SCO GROUP INCSold outFebruary 14, 200800.0%
VIEWPOINT CORPOctober 29, 20077,934,5368.1%
ARMSTRONG HOLDINGS INC /PA/Sold outFebruary 14, 200700.0%
SEROLOGICALS CORPMay 08, 20061,866,6005.5%
NEIGHBORCARE INCFebruary 14, 20052,395,2935.4%
WARNACO GROUP INC /DE/February 17, 20042,060,5134.6%
IPC INFORMATION SYSTEMS INCFebruary 14, 2000327,9003.8%

Compare quarters

Export CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD's holdings